- Overview
- Products
- Negative Pressure Wound Therapy
- Wound Dressings and Compression
- Skin Care
- Surgical
- Vascular Access
- Sterilization Monitoring
- Temperature Management
- Adhesive Securement
- Patient Monitoring
- Respiratory Protection
- Securement and Immobilization
- Prevention
- Pressure Injuries
- Adhesive Skin Damage
- Moisture Associated Skin Damage
- Bloodstream Infections
- Hypothermia
- Tube and Line Dislodgement
- Cross Contamination
- Electrode-Related Alarm Fatigue
- Hand Hygiene
- Treatment
- Pressure Injuries
- Diabetic Foot Ulcers
- Venous Leg Ulcers
- Traumatic Wounds
- Surgical Incisions
- Open Abdomen
- Incontinence-Associated Dermatitis
- Edema and Lymphedema
- Oncology Care
- C. difficile infection
- Resources
- Education
- Support
Our apologies...
An error has occurred while submitting. Please try again later...
Thank you!
Your form was submitted successfully
Prevena Central for cardiothoracic surgery
Convenient. Curated. Connected. Training for the use of 3M™ Prevena™ Therapy in cardiothoracic surgery.
-
Calculations are derived based on relative patient group incidence rate reported in this study.
*Statistically significant (p<0.05).
1. Grauhan O, et al. Prevention of post sternotomy wound infections in obese patients by negative pressure wound therapy. J Thorac Cardiovasc Surg. 2013;145:1387-1392.
2. Grauhan O, et al. Effect of surgical incision management on wound infections in a post sternotomy patient population. Int Wound J. 2014;11:6-9.
Proactive Risk Management (PRM) with Prevena Therapy
See the evidence behind the use of Prevena Therapy in cardiothoracic surgery.
-
Find detailed information about clinical studies for the use of Prevena Therapy in cardiothoracic surgery, including outcomes and cost-effectiveness.
-
Download the summary of findings for the use of Prevena Therapy following sternotomy surgery.
-
View an illustrative guide to aid in risk stratification for cardiothoracic surgery.
Learn more about the use of Prevena Therapy in cardiovascular surgery or request a product demonstration.
3M™ Prevena™ 125 and 3M™ Prevena™ Plus 125 Therapy Units manage the environment of closed surgical incisions and remove fluid away from the surgical incision via the application of -125mmHg continuous negative pressure. When used with legally marketed compatible dressings, Prevena 125 and Prevena Plus 125 Therapy Units are intended to aid in reducing the incidence of seroma and, in patients at risk for post-operative infections, aid in reducing the incidence of superficial surgical site infection in Class I and II wounds.
The effectiveness of Prevena Therapy in reducing the incidence of SSIs and seroma in all surgical procedures and populations has not been demonstrated. See full indications for use and limitations at myKCI.com.
NOTE: Applicable therapy units include Prevena™ 125 and Prevena™ Plus 125 Therapy Unit 7 Day.
The indication statement does not apply to the Prevena Plus 125 Therapy Unit (14-day) that comes with the 3M™ Prevena Restor™ System Kits (see Prevena Restor indications for use).
The 3M™ Prevena Restor™ Incision Management System is intended to manage the environment of surgical incisions that continue to drain following sutured or stapled closure by maintaining a closed environment and removing exudate via the application of negative pressure wound therapy.
NOTE: Specific indications, limitations, contraindications, warnings, precautions and safety information exist for these products and therapies. Please consult a clinician and product instructions for use prior to application. Rx only.
